Aptose Biosciences Inc. (NASDAQ:APTO) Q1 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Josh and I will be your conference operator today.
Aptose Biosciences Inc. (APTO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | -100% | 0% |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.20 | 100,000 | 613,252 | 2024-11-25 | Filing | ||
| $3.14 | 17,000 | 17,000 | 2023-09-22 | Filing | ||
| $0.68 | 10,000 | Officer, Director | 363,252 | 2022-09-19 | Filing | |
| $0.68 | 10,000 | Officer | 10,000 | 2022-09-19 | Filing | |
| $0.97 | 10,000 | Officer, Director | 353,252 | 2022-06-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.62 | 60,000 | Large Shareholder | 8,888,275 | 2021-08-05 | Filing | |
| $3.24 | 9,600 | Director | 15,000 | 2021-06-22 | Filing | |
| $3.35 | 15,400 | Director | 24,600 | 2021-06-21 | Filing | |
| $4.11 | 10,000 | Director | 40,000 | 2020-12-22 | Filing | |
| $4.01 | 10,000 | Director | 50,000 | 2020-12-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,500,000 | $563,250 | 0.14% | |
| 2. | 703,384 | $158,472 | 0% | |
| 3. | 592,829 | $133,564 | 0% | |
| 4. | 57,827 | $13,011 | 0% | |
| 5. | 19,206 | $4,402 | 0% |
News See All
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.
Aptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Hope, and I will be your conference operator today.
Aptose Biosciences Inc. (NASDAQ:APTO) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Zeda and I will be your conference operator today.
Aptose Biosciences Inc. (NASDAQ:APTO) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Antoine Alexander and I will be your conference operator today.
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2022 Earnings Call Transcript
Operator: Hello and thank you for standing by and welcome to Aptose Biosciences reports for the Fourth Quarter and Yearend 2022 Conference Call. At this time, all participants on a listen-only mode.
10 Micro-Cap Stocks to Buy According to Hedge Funds
In this article, we will discuss 10 micro-cap stocks to buy according to hedge funds.
5 Stocks to Buy Under $15 According to Travis Cocke’s Voss Capital
In this article, we discuss the 5 stocks to buy under $15 according to Travis Cocke’s Voss Capital.
Hedge Funds Are Crazy About Aptose Biosciences Inc (APTO)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
10 Best Small-Cap Biotech Stocks Under $10 in 2021
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
Billionaire Hedge Funds
